Concord Drugs Board to meet on May 27 for FY26 Financial Results

Concord Drugs Ltd has announced that its Board of Directors will convene a meeting on May 27, 2026. The main purpose of this meeting is to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. In compliance with insider trading regulations, the trading window for the company's equity shares has been closed for all designated persons and their immediate relatives. This closure will remain in effect until 48 hours after the financial results are officially declared.